Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Instrumentation : an IOP and SISSA Journal|December 12, 2017
CMOS Active Pixel Sensors as energy-range detectors for proton Computed TomographyM Esposito, T Anaxagoras, P M Evans, et al.Journal of Instrumentation : an IOP and SISSA Journal|January 26, 2018
Proton tracking for medical imaging and dosimetryJ T Taylor, P P Allport, G L Casse, et al.International Journal of Molecular Sciences|October 16, 2025
Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNAMarina Danilenko, Sharanya Nath, Jack Baines, et al.Genes, Chromosomes & Cancer|August 27, 2022
Loss of ALK hotspot mutations in relapsed neuroblastomaLisa M Allinson, Aaron Potts, Angharad Goodman, et al.Molecular Cancer Therapeutics|December 28, 2019
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast CancerWaleed S Al Amri, Lisa M Allinson, Diana E Baxter, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|November 14, 2018
PRaVDA: The first solid-state system for proton computed tomographyMichela Esposito, Chris Waltham, Jonathan T Taylor, et al.Medical Physics|November 4, 2016
An experimental demonstration of a new type of proton computed tomography using a novel silicon tracking detectorJ T Taylor, G Poludniowski, T Price, et al.Oncotarget|November 6, 2015
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemiaAshleigh Herriott, Susan J Tudhope, Gesa Junge, et al.JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.Pageof 4